In 2010, Study to find novel therapies for aggressive and non-responding or relapsing patients. With MMTV-neu mouse & 87 human breast tumors

Background: analyzed antitumor potential in a well established and clinically relevant model of ErbB2-driven metastatic breast cancer.

You can read the full story here => https://molecular-cancer.biomedcentral.com/articles/10.1186/1476-4598-9-196https://molecular-cancer.biomedcentral.com/articles/10.1186/1476-4598-9-196